AMD Appeal
Help turn research into real world treatments
Your gift will support research into age‑related macular degeneration, giving hope for a brighter world for those living with vision loss.
Participating in clinical research and trials is such a generous act. People volunteer their time, personal health information, and sometimes even their own DNA, in the hope that someday, another person will have a proven treatment for their own medical condition.
It’s the stuff of dreams, to watch years of research turn into real world treatments, and it has recently become a reality for Olga Maxwell.
Sixteen years ago, when Olga was just 50 years old, she was diagnosed with age-related macular degeneration (AMD). Her dry type of AMD – also known as geographic atrophy – is a disease that affects the central part of the retina at the back of the eye.
Until recently there has been no treatment for this type of AMD, but thanks to an extensive international research effort, including CERA, the first treatment to slow its progress is now available.
Your donations help to power research at CERA so new and improved treatments can be discovered for the many eye conditions that affect Australians.
Payment details
Leading the way
Research is a steady, methodical process, with each step we take potentially opening up new avenues of exploration.
Our incredible researchers are blazing new paths that range from understanding basic mechanisms to full genomic mapping.
We’ve compiled huge amounts of data that can inform future treatments for AMD, from extensive family histories to image banks that can be analysed by world-leading scientists – even Artificial Intelligence technology.
Thank you for supporting our AMD Appeal
From everyone at CERA, we are truly grateful for your support of research with real-life impact.
Every donation, whatever the size, brings our researchers closer to discoveries that increase the success of AMD treatments and help preserve sight for many Australians.
Thank you for helping us bring hope to people affected by vision loss and blindness.